IRON Relative Valuation
IRON's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, IRON is overvalued; if below, it's undervalued.
Historical Valuation
Disc Medicine Inc (IRON) is now in the Fair zone, suggesting that its current forward PS ratio of 169.28 is considered Fairly compared with the five-year average of -11.00. The fair price of Disc Medicine Inc (IRON) is between -- to -- according to relative valuation methord.
Relative Value
Fair Zone
-----
Current Price：80.94
Fair
-11.69
PE
1Y
3Y
5Y
-10.06
EV/EBITDA
Disc Medicine Inc. (IRON) has a current EV/EBITDA of -10.06. The 5-year average EV/EBITDA is -6.97. The thresholds are as follows: Strongly Undervalued below -11.18, Undervalued between -11.18 and -9.07, Fairly Valued between -4.87 and -9.07, Overvalued between -4.87 and -2.77, and Strongly Overvalued above -2.77. The current Forward EV/EBITDA of -10.06 falls within the Undervalued range.
-8.70
EV/EBIT
Disc Medicine Inc. (IRON) has a current EV/EBIT of -8.70. The 5-year average EV/EBIT is -7.54. The thresholds are as follows: Strongly Undervalued below -12.11, Undervalued between -12.11 and -9.82, Fairly Valued between -5.26 and -9.82, Overvalued between -5.26 and -2.97, and Strongly Overvalued above -2.97. The current Forward EV/EBIT of -8.70 falls within the Historic Trend Line -Fairly Valued range.
169.28
PS
Disc Medicine Inc. (IRON) has a current PS of 169.28. The 5-year average PS is 466.56. The thresholds are as follows: Strongly Undervalued below -2709.37, Undervalued between -2709.37 and -1121.40, Fairly Valued between 2054.53 and -1121.40, Overvalued between 2054.53 and 3642.50, and Strongly Overvalued above 3642.50. The current Forward PS of 169.28 falls within the Historic Trend Line -Fairly Valued range.
-13.30
P/OCF
Disc Medicine Inc. (IRON) has a current P/OCF of -13.30. The 5-year average P/OCF is -10.95. The thresholds are as follows: Strongly Undervalued below -17.60, Undervalued between -17.60 and -14.28, Fairly Valued between -7.63 and -14.28, Overvalued between -7.63 and -4.30, and Strongly Overvalued above -4.30. The current Forward P/OCF of -13.30 falls within the Historic Trend Line -Fairly Valued range.
-15.38
P/FCF
Disc Medicine Inc. (IRON) has a current P/FCF of -15.38. The 5-year average P/FCF is -12.82. The thresholds are as follows: Strongly Undervalued below -21.29, Undervalued between -21.29 and -17.05, Fairly Valued between -8.58 and -17.05, Overvalued between -8.58 and -4.34, and Strongly Overvalued above -4.34. The current Forward P/FCF of -15.38 falls within the Historic Trend Line -Fairly Valued range.
Disc Medicine Inc (IRON) has a current Price-to-Book (P/B) ratio of 4.83. Compared to its 3-year average P/B ratio of 3.35 , the current P/B ratio is approximately 44.12% higher. Relative to its 5-year average P/B ratio of 3.34, the current P/B ratio is about 44.78% higher. Disc Medicine Inc (IRON) has a Forward Free Cash Flow (FCF) yield of approximately -5.56%. Compared to its 3-year average FCF yield of -6.51%, the current FCF yield is approximately -14.64% lower. Relative to its 5-year average FCF yield of -6.56% , the current FCF yield is about -15.23% lower.
4.83
P/B
Median3y
3.35
Median5y
3.34
-5.56
FCF Yield
Median3y
-6.51
Median5y
-6.56
Competitors Valuation Multiple
The average P/S ratio for IRON's competitors is 47.68, providing a benchmark for relative valuation. Disc Medicine Inc Corp (IRON) exhibits a P/S ratio of 169.28, which is 255.01% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
Performance Decomposition
1Y
3Y
5Y
Market capitalization of IRON increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of IRON in the past 1 year is driven by Unknown.
People Also Watch
UNFI
United Natural Foods Inc
33.3USD
-1.68%
EXPI
eXp World Holdings Inc
9.43USD
0.86%
BHE
Benchmark Electronics Inc
44.6USD
-1.61%
NABL
N-Able Inc
7.44USD
2.34%
AMPH
Amphastar Pharmaceuticals Inc
27.33USD
-1.05%
BLTE
Belite Bio Inc
164.2USD
2.51%
SBLK
Star Bulk Carriers Corp
20.51USD
0.54%
BIO.B
Bio Rad Laboratories Inc
310.7USD
0.00%
SONO
Sonos Inc
16.65USD
-2.29%
NGVT
Ingevity Corp
61.96USD
-1.45%
Frequently Asked Questions
Is Disc Medicine Inc (IRON) currently overvalued or undervalued?
Disc Medicine Inc (IRON) is now in the Fair zone, suggesting that its current forward PS ratio of 169.28 is considered Fairly compared with the five-year average of -11.00. The fair price of Disc Medicine Inc (IRON) is between to according to relative valuation methord.
What is Disc Medicine Inc (IRON) fair value?
IRON's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Disc Medicine Inc (IRON) is between to according to relative valuation methord.
How does IRON's valuation metrics compare to the industry average?
The average P/S ratio for IRON's competitors is 47.68, providing a benchmark for relative valuation. Disc Medicine Inc Corp (IRON) exhibits a P/S ratio of 169.28, which is 255.01% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
What is the current P/B ratio for Disc Medicine Inc (IRON) as of Jan 08 2026?
As of Jan 08 2026, Disc Medicine Inc (IRON) has a P/B ratio of 4.83. This indicates that the market values IRON at 4.83 times its book value.
What is the current FCF Yield for Disc Medicine Inc (IRON) as of Jan 08 2026?
As of Jan 08 2026, Disc Medicine Inc (IRON) has a FCF Yield of -5.56%. This means that for every dollar of Disc Medicine Inc’s market capitalization, the company generates -5.56 cents in free cash flow.
What is the current Forward P/E ratio for Disc Medicine Inc (IRON) as of Jan 08 2026?
As of Jan 08 2026, Disc Medicine Inc (IRON) has a Forward P/E ratio of -11.69. This means the market is willing to pay $-11.69 for every dollar of Disc Medicine Inc’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Disc Medicine Inc (IRON) as of Jan 08 2026?
As of Jan 08 2026, Disc Medicine Inc (IRON) has a Forward P/S ratio of 169.28. This means the market is valuing IRON at $169.28 for every dollar of expected revenue over the next 12 months.